A new study highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein which is overexpressed in several cancer types and promotes tumor progression.
from Breast Cancer News -- ScienceDaily https://ift.tt/wboNFft
0 comments:
Post a Comment